Presentation Information

[28-14-pm13]Development of novel BRD4 degraders using HIV-derived peptides as E3 ligase ligands

○Kohei Tsuji1, Xueyuan Huang1, Maho Miyamoto2,3, Hidetomo Yokoo2, Takuya Kobayakawa1, Yosuke Demizu2,3,4, Hirokazu Tamamura1 (1. Laboratory for Biomaterials and Bioengineering, Institute of Science Tokyo, 2. National Institute of Health Sciences, 3. Graduate School of Medical Life Science, Yokohama City University, 4. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Division of Pharmaceutical Science of Okayama University)